Extractions
One row per ingestion event — the raw audit log of every thread the agent processed.
3 rows
| ID | Saved at | Program | Vendor | Service | Thread subject | Messages | Last message | Summary |
|---|---|---|---|---|---|---|---|---|
| d882b623 | 2026-05-13 18:58:07Z | syngap1 | primara-pharma-partners | — | Re: Introduction and Survey for Initial Regulatory Assessment (SYNGAP1) | 2 | — | PrimeRA Pharma Partners has been engaged to deliver an Initial Regulatory Assessment for Nome's SYNGAP1 n-of-1 ASO program (two splice-swit… |
| 921fce68 | 2026-05-13 18:41:26Z | syngap1 | axolabs | — | Fwd: RFPs for 2 SYNGAP1 programs - Nome therapeutics <>Axolabs | 2 | — | Nome Therapeutics is engaging Axolabs (LGC Group) to design and screen ASOs against two intronic splice-altering SYNGAP1 variants (c.3583-9… |
| 049fbfea | 2026-05-13 18:40:16Z | syngap1 | evotec | — | Fwd: SYNGAP1 programs - Nome | 3 | — | Nome sent Evotec two RFPs for splice-modulating ASO programs targeting SYNGAP1 c.3583-9G>A (iPSC line available) and c.3583-6G>A (no iPSC l… |